secwatch.observer — SEC 8-K summary
======================================

Issuer:     GRI Bio, Inc. (GRI)
CIK:        0001824293
Form:       8-K
Filed at:   2026-01-16T23:59:59+00:00
Accession:  0001824293-26-000011
Event type: regulatory
Sentiment:  positive
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

GRI Bio conditionally regains Nasdaq equity compliance after prior deficiency
-----------------------------------------------------------------------------

- Nasdaq Staff notified GRI Bio on Jan 15, 2026 that it conditionally regained compliance with the Stockholders' Equity Requirement (Nasdaq Listing Rule 5550(b)(1)).
- The requirement mandates at least $2.5 million in stockholders' equity for companies with market value under $35 million and annual net income below $500,000.
- Non-compliance was previously reported in a Dec 2, 2025 8-K based on the Sept 30, 2025 10-Q.
- If future Exchange Act reports fail to show compliance, common stock may again face delisting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1824293/000182429326000011/0001824293-26-000011-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1824293/000182429326000011/val-20260115.htm
  HTML page:      https://secwatch.observer/filing/0001824293-26-000011

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer